Status:
UNKNOWN
Methylation Analysis of Circulating Tumor DNA in Gastric Cancer
Lead Sponsor:
Shanghai Zhongshan Hospital
Conditions:
Stomach Neoplasms
Circulating Tumor DNA
Eligibility:
All Genders
18-75 years
Brief Summary
The primary purpose of this trial is to describe the profile of ctDNA methylation in gastric cancer. The second purpose is to demonstrate the correlation between the plasma ctDNA methylation status an...
Detailed Description
Gastric cancer represents one of the common malignant tumors in China, with high incidence and mortality rates. Surgery is the conventional treatment option for early and intermediate stage gastric ca...
Eligibility Criteria
Inclusion
- The subject is scheduled to undergo an endoscopy because of medical indications.
- The subject must have personally signed and dated the patient informed consent form indicating that he/she has been informed of all pertinent aspects of the study.
- The subject must be willing and able to comply with all study procedures.
Exclusion
- The subject who is unable to undergo gastroscopy.
- The subject with previous total or partial gastrectomy.
- The subject has other severe acute or chronic medical or psychiatric condition or laboratory abnormality that may interfere with the interpretation of study results and in the judgment of the investigator would make the subject unsuitable for entry into the study.
- The subject is unwilling or unable to provide signed informed consent.
- The subject who is pregnant.
Key Trial Info
Start Date :
October 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2025
Estimated Enrollment :
540 Patients enrolled
Trial Details
Trial ID
NCT04511559
Start Date
October 1 2020
End Date
May 1 2025
Last Update
August 13 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.